aurobindo pharma's wholly-owned arm theranym inks biologics mfg deal with merck sharp & dohme
Published 4 months ago • 295 plays • Length 2:10
Download video MP4
Download video MP3
Similar videos
-
7:48
see a lot of potential in the biologics space: aurobindo pharma | n18v | cnbc tv18
-
2:35
aurobindo pharma under pressure after us fda issues warning letter for eugia unit iii | cnbc tv18
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
10:40
us business was impacted by seasonality in q1fy25: aurobindo pharma | cnbc tv18
-
9:04
would like to backward integrate into contract development: aurobindo pharma | cnbc tv18
-
4:40
economic crisis: “active action or finally new elections” - clear demand to the government
-
3:18
nvidia is leaps and bounds ahead of amd on the ai story, says susquehanna's christopher rolland
-
5:26
apple is de-risked, says deepwater's doug clinton
-
5:33
#marketswithmsi interview with cnbc tv 18 | aurobindo pharma, zomato, cadila health, dixon tech
-
1:23
link ron95 subsidies to vehicle owners instead of ics, says fomca
-
1:54
aurobindo pharma's arm apl healthcare units get vai status from u.s. fda | halftime report
-
5:38
google search benefiting from generative ai, says deepwater's gene munster
-
3:24
aurobindo pharma under pressure after us fda issues 9 observations for eugia pharma's unit iii
-
1:43
usfda inspection of eugia-iii unit of aurobindo pharma underway, stock under pressure | cnbc tv18
-
3:02
aurobindo pharma under pressure after us fda warning letter, divi's lab rises on positive news
-
1:19
macquarie upgrades stocks of aurobindo pharma & ipca laboratories | bazaar open exchange
-
0:48
aurobindo pharma will consider a proposal for a buyback in its board meet on july 18 | cnbc tv18
-
4:22
alphabet is not a 'favored' name among investors right now, says oppenheimer's jason helfstein
-
1:16
aurobindo pharma slips in trade after us fda issues 10 observations to the api unit in telangana
-
1:32
aurobindo pharma's key unit inspected by us fda with zero observations
-
1:55
aurobindo pharma gains in trade as it starts commercial production at 4 plants | cnbc tv18
-
1:35
aurobindo: shot in the arm
Clip.africa.com - Privacy-policy